Efficacy of ciclesonide vs fixed combination of fluticasone propionate/salmeterol vs placebo in patients with mild persistent asthma (12 to 75 y) (BY9010/M1-132)

Study identifier:BY9010/M1-132

ClinicalTrials.gov identifier:NCT00163358

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Efficacy of ciclesonide and of a fixed combination with fluticasone propionate and salmeterol versus placebo on long-term asthma control

Medical condition

asthma

Phase

Phase 3

Healthy volunteers

No

Study drug

Ciclesonide

Sex

All

Actual Enrollment

630

Study type

Interventional

Age

12 Years - 75 Years

Date

Study Start Date: 01 Sept 2003
Primary Completion Date: 01 Oct 2005
Study Completion Date: 01 Oct 2005

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Oct 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria